Effects of cannabinoids on the immune system and central nervous system: Therapeutic implications

BioDrugs

Volumn 12, Issue 5, 1999, Pages 317-326

  Molina Holgado, E ^a   Guaza, C ^a   Borrell, J ^a   Molina Holgado, F ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CYTOKINE; NITRIC OXIDE; PROSTANOID;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNE SYSTEM; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0032729909     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199912050-00001     Document Type: Review

References (111)

1. 1. R. Mechoulam 1986 The pharmacology of Cannabis sativa R. Mechoulam Cannabinoids as therapeutic agents CRC Boca Raton (FL) 1 19 Mechoulam R. The pharmacology of Cannabis sativa. In: Mechoulam R, editor. Cannabinoids as therapeutic agents. Boca Raton (FL): CRC, 1986: 1–19
2. 2. Y. Gaoni R. Mechoulam 1964 Isolation, structure elucidation and partial synthesis of an active constituent of hashish J Am Chem Soc 1646-47 11 20 Gaoni Y, Mechoulam R. Isolation, structure elucidation and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964; 1646-47: 11–20
3. 3. L.A. Matsuda S.J. Lolait M.J. Brownstein 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 561 4 2165569 1:CAS:528:DyaK3cXls1Ghu7w%3D Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–4
4. 4. D. Shire C. Carillon M. Kaghad 1995 An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing J Biol Chem 270 3726 31 7876112 1:CAS:528:DyaK2MXjvVyrsLg%3D Shire D, Carillon C, Kaghad M, et al. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 1995; 270: 3726–31
5. 5. S. Munro K.L. Thomas M. Abu-Shaar 1993 Molecular characterization of a peripheral receptor for cannabinoids Nature 365 61 5 7689702 1:CAS:528:DyaK3sXmsVWiurk%3D Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–5
6. 6. G.B. Stefano Y. Liu M.S. Goligorsky 1996 Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes J Biol Chem 271 32 19238 42 8702604 1:CAS:528:DyaK28XkvFyntbg%3D Stefano GB, Liu Y, Goligorsky MS, et al. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 1996; 271(32): 19238–42
7. 7. W.A. Devane L. Hanus A. Breuer 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946 9 1470919 1:CAS:528:DyaK3sXpvVKntg%3D%3D Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946–9
8. 8. R. Mechoulam S. Ben-Shabat L. Hanus 1995 Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 83 90 7605349 1:CAS:528:DyaK2MXmsl2ks7Y%3D Mechoulam R, Ben-Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83–90
9. 9. C.C. Felder J.S. Veluz H.L. Williams 1992 Cannabinoid agonists stimulate both receptor and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones Mol Pharmacol 42 838 45 1331766 1:CAS:528:DyaK3sXntlCqsA%3D%3D Felder CC, Veluz JS, Williams HL, et al. Cannabinoid agonists stimulate both receptor and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 1992; 42: 838–45
10. 10. N.E. Kaminski M.E. Abood F.K. Kessler 1992 Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation Mol Pharmacol 42 736 42 1279376 1:CAS:528:DyaK3sXjt1ynsA%3D%3D Kaminski NE, Abood ME, Kessler FK, et al. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 1992; 42: 736–42
11. 11. T.W. Kiein H. Friedman S. Specter 1998 Marijuana, immunity and infection J Neuroimmunol 83 102 15 Kiein TW, Friedman H, Specter S. Marijuana, immunity and infection. J Neuroimmunol 1998; 83: 102–15
12. 12. T.W. Kiein C. Newton H. Friedman 1998 Cannabinoid receptors and immunity Imunol Today 19 373 81 Kiein TW, Newton C, Friedman H. Cannabinoid receptors and immunity. Imunol Today 1998; 19: 373–81
13. 13. Y.J. Jeon K.H. Yang J.T. Pulaski 1996 Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydro-cannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation Mol Pharmacol 50 334 41 8700141 1:CAS:528:DyaK28XkvFCqtbw%3D Jeon YJ, Yang KH, Pulaski JT, et al. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydro-cannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation. Mol Pharmacol 1996; 50: 334–41
14. 14. F. Molina-Holgado A. Lledo C. Guaza 1997 Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler’s virus or endotoxin in astrocytes Neuroreport 8 1929 33 9223079 1:CAS:528:DyaK2sXks1Cis7w%3D Molina-Holgado F, Lledo A, Guaza C. Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler’s virus or endotoxin in astrocytes. Neuroreport 1997; 8: 1929–33
15. 15. F. Molina-Holgado E. Molina-Holgado C. Guaza 1998 The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler’s murine encephalomyelitis virus by a receptor-mediated pathway FEBS Lett 433 139 42 9738948 1:CAS:528:DyaK1cXltlemt7g%3D Molina-Holgado F, Molina-Holgado E, Guaza C. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler’s murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett 1998; 433: 139–42
16. 16. W.D. Lyman J.R. Sonett C.F. Brosnan 1989 Delta 9-tetrahydro-cannabinol: a novel treatment for experimental autoimmune encephalomyelitis J Neuroimmunol 23 73 81 2542370 1:CAS:528:DyaL1MXktlegs7s%3D Lyman WD, Sonett JR, Brosnan CF, et al. Delta 9-tetrahydro-cannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol 1989; 23: 73–81
17. 17. I. Wirguin R. Mechoulam A. Breuer 1994 Suppression of experimental autoimmune encephalomyelitis by cannabinoids Immunopharmacology 28 209 14 7852052 1:CAS:528:DyaK2cXmslajsbs%3D Wirguin I, Mechoulam R, Breuer A, et al. Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology 1994; 28: 209–14
18. 18. Zheng ZM, Specter S. Suppression by delta-9-tetrahydrocannabinol of lipopolysaccharide induced and intrinsic tyrosine phosphorylation and protein expression in mouse peritoneal macrophages. Biochem Pharmacol 1994; 47: 2243–52
19. 19. B.E. Juel-Jensen 1972 Cannabis and recurrent herpes simplex [letter] Br Med J 4 835 296 5083899 1:STN:280:DyaE3s%2FjtlGkuw%3D%3D Juel-Jensen BE. Cannabis and recurrent herpes simplex [letter]. Br Med J 1972; 4(835): 296
20. 20. A.R. Schatz W.S. Koh N.E. Kaminski 1993 Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function Immunopharmacology 26 129 37 8282537 1:CAS:528:DyaK3sXms1agtr0%3D Schatz AR, Koh WS, Kaminski NE. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology 1993; 26: 129–37
21. 21. A.R. Schatz M. Lee R.B. Condie 1997 Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system Toxicol Appl Pharmacol 142 278 87 9070350 1:CAS:528:DyaK2sXhsFaqtrY%3D Schatz AR, Lee M, Condie RB, et al. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 1997; 142: 278–87
22. 22. M. Lee K.H. Yang N.E. Kaminski 1995 Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes J Pharmacol Exp Ther 275 529 36 7473135 1:CAS:528:DyaK2MXpsF2htLc%3D Lee M, Yang KH, Kaminski NE. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 1995; 275: 529–36
23. 23. A.B. Lynn M. Herkenham 1994 Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids J Pharmacol Exp Ther 268 1612 23 8138973 1:CAS:528:DyaK2cXis1WhsLs%3D Lynn AB, Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 1994; 268: 1612–23
24. 24. G.A. Cabrai P. DA. Dove 1998 Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease J Neuroimmunol 83 116 23 Cabrai GA, Dove Pettit DA. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol 1998; 83: 116–23
25. 25. G.A. Cabrai J.C. Lockmuller E.M. Mishkin 1986 Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse Proc Soc Exp Biol Med 181 2 305 11 Cabrai GA, Lockmuller JC, Mishkin EM. Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc Soc Exp Biol Med 1986; 181(2): 305–11
26. 26. M.S. Smith Y. Yamamoto C. Newton 1997 Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila Proc Soc Exp Biol Med 214 1 69 75 9012363 1:CAS:528:DyaK2sXnvFWnsw%3D%3D Smith MS, Yamamoto Y, Newton C, et al. Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila. Proc Soc Exp Biol Med 1997; 214(1): 69–75
27. 27. J. Ongradi S. Specter A. Horvath 1998 Combined in vitro effect of marijuana and retrovirus on the activity of mouse natural killer cells Pathol Oncol Res 4 3 191 9 9761937 1:STN:280:DyaK1cvjslClsA%3D%3D Ongradi J, Specter S, Horvath A, et al. Combined in vitro effect of marijuana and retrovirus on the activity of mouse natural killer cells. Pathol Oncol Res 1998; 4(3): 191–9
28. 28. R.G. Coffey E. Snella K. Johnson 1996 Inhibition of macrophage nitric oxide production by tetrahydrocannabinol in vivo and in vitro Int J Immunopharmacol 18 12 749 52 9172018 1:CAS:528:DyaK2sXjs1Gltrs%3D Coffey RG, Snella E, Johnson K, et al. Inhibition of macrophage nitric oxide production by tetrahydrocannabinol in vivo and in vitro. Int J Immunopharmacol 1996; 18(12): 749–52
29. 29. R.G. Coffey Y. Yamamoto E. Snella 1996 Tetrahydrocannabinol inhibition of macrophage nitric oxide production Biochem Pharmacol 52 5 743 51 8765472 1:CAS:528:DyaK28XltFOrsLw%3D Coffey RG, Yamamoto Y, Snella E, et al. Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem Pharmacol 1996; 52(5): 743–51
30. 30. H. Ovadia A. Wohlman R. Mechoulam 1995 Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens Neuropharmacology 34 2 1175 80 Ovadia H, Wohlman A, Mechoulam R, et al. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 1995; 34(2): 1175–80
31. 31. G. Patrini P. Sacerdote D. Fuzio 1997 Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound J Neuroimmunol 80 1-2 1143 8 Patrini G, Sacerdote P, Fuzio D, et al. Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound. J Neuroimmunol 1997; 80(1-2): 1143–8
32. 32. G.G. Nahas N. Suciu-Foca J.P. Armand 1974 Inhibition of cellular mediated immunity in marihuana smokers Science 183 123 419 20 4271816 1:CAS:528:DyaE2cXks1Wqt70%3D Nahas GG, Suciu-Foca N, Armand JP, et al. Inhibition of cellular mediated immunity in marihuana smokers. Science 1974; 183(123): 419–20
33. 33. S.C. White S.C. Brin B.W. Janicki 1975 Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers Science 188 4183 71 2 1078732 1:CAS:528:DyaE2MXhs1Gjs7k%3D White SC, Brin SC, Janicki BW. Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers. Science 1975; 188(4183): 71–2
34. 34. G.S. Rachelefsky G. Opelz M.R. Mickey 1976 Intact humoral and cell-mediated immunity in chronic marijuana smoking J Allergy Clin Immunol 58 4 483 90 135011 1:STN:280:DyaE2s%2Fgs1ygsQ%3D%3D Rachelefsky GS, Opelz G, Mickey MR, et al. Intact humoral and cell-mediated immunity in chronic marijuana smoking. J Allergy Clin Immunol 1976; 58(4): 483–90
35. 35. G.G. Nahas G.S. Oserman 1991 Altered serum immunoglobulin concentration in chronic marijuana smokers Adv Exp Biol Med 288 25 32 1:STN:280:DyaK38%2FlvVajsg%3D%3D Nahas GG, Oserman GS. Altered serum immunoglobulin concentration in chronic marijuana smokers. Adv Exp Biol Med 1991; 288: 25–32
36. 36. E.M. Dax N.S. Pilotte W.H. Adler 1989 The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function J Steroid Biochem 34 1-6 263 70 2560514 1:CAS:528:DyaK3cXhtFajtro%3D Dax EM, Pilotte NS, Adler WH, et al. The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J Steroid Biochem 1989; 34(1-6): 263–70
37. 37. P. Massi P. Sacerdote W. Ponti 1998 Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters J Neuroimmunol 92 1-2 60 6 9916880 1:CAS:528:DyaK1cXnvVWisrY%3D Massi P, Sacerdote P, Ponti W, et al. Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters. J Neuroimmunol 1998; 92(1-2): 60–6
38. 38. Y. Kawakami T.W. Klein C. Newton 1988 Suppression by cannabinoids of a cloned cell line with natural killer cell activity Proc Soc Exp Biol Med 187 3 355 9 2831542 1:CAS:528:DyaL1cXhs1WisLk%3D Kawakami Y, Klein TW, Newton C, et al. Suppression by cannabinoids of a cloned cell line with natural killer cell activity. Proc Soc Exp Biol Med 1988; 187(3): 355–9
39. 39. Y. Ouyang S.G. Hwang S.H. Han 1998 Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells Mol Pharmacol 53 676 83 9547358 1:CAS:528:DyaK1cXislCgtLk%3D Ouyang Y, Hwang SG, Han SH, et al. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol Pharmacol 1998; 53: 676–83
40. 40. T.W. Klein C. Newton H. Friedman 1998 Cannabinoid receptors and the cytokine network Adv Exp Biol Med 437 215 22 1:CAS:528:DyaK1cXmvFGksr0%3D Klein TW, Newton C, Friedman H. Cannabinoid receptors and the cytokine network. Adv Exp Biol Med 1998; 437: 215–22
41. 41. H. Friedman T. Klein S. Specter 1988 Drugs of abuse and virus susceptibility Adv Biochem Psychopharmacol 44 125 37 2840802 1:STN:280:DyaL1c3ptF2jtA%3D%3D Friedman H, Klein T, Specter S, et al. Drugs of abuse and virus susceptibility. Adv Biochem Psychopharmacol 1988; 44: 125–37
42. 42. D. Burnette-Curley G.A. Cabrai 1995 Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9 tetra-hydrocannabinol Proc Soc Exp Biol Med 210 1 64 76 7675800 1:CAS:528:DyaK2MXot1Khuro%3D Burnette-Curley D, Cabrai GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9 tetra-hydrocannabinol. Proc Soc Exp Biol Med 1995; 210(1): 64–76
43. 43. R. Gallily A. Yamin Y. Waksman 1997 Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a non-psychotropic cannabinoid J Pharmacol Exp Ther 283 918 24 9353414 1:CAS:528:DyaK2sXnsV2mtrg%3D Gallily R, Yamin A, Waksman Y, et al. Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a non-psychotropic cannabinoid. J Pharmacol Exp Ther 1997; 283: 918–24
44. 44. K. Varga J.A. Wagner D.T. Bridgen 1998 Platelet and macro-phage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension FASEB J 11 1035 44 Varga K, Wagner JA, Bridgen DT, et al. Platelet and macro-phage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998; 11: 1035–44
45. 45. H. Schwarz F.J. Blanco M. Lotz 1994 Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis J Neuroimmunol 55 107 15 7962480 1:CAS:528:DyaK2MXitlams7o%3D Schwarz H, Blanco FJ, Lotz M. Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 1994; 55:107–15
46. 46. W. Zhu H. Friedman T.W. Klein 1998 Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1 J Pharmacol Exp Ther 286 2 1103 9 9694974 1:CAS:528:DyaK1cXlsVWhtr4%3D Zhu W, Friedman H, Klein TW. Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther 1998; 286(2): 1103–9
47. 47. Z.M. Zheng S. Specter H. Friedman 1992 Inhibition by delta-9-tetra-hydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages Int J Immunopharmacol 14 8 1445 52 1334476 1:CAS:528:DyaK3sXhtFKmtr0%3D Zheng ZM, Specter S, Friedman H. Inhibition by delta-9-tetra-hydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int J Immunopharmacol 1992; 14(8): 1445–52
48. 48. R. Condie A. Herring W.S. Koh 1996 Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2 J Biol Chem 271 13175 83 8662742 1:CAS:528:DyaK28XjtlGisL0%3D Condie R, Herring A, Koh WS, et al. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. J Biol Chem 1996; 271: 13175–83
49. 49. A.C. Herring W.S. Koh N.E. Kaminski 1998 Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid Biochem Pharmacol 55 7 1013 23 9605425 1:CAS:528:DyaK1cXit12qs74%3D Herring AC, Koh WS, Kaminski NE. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid. Biochem Pharmacol 1998; 55(7): 1013–23
50. 50. E. Snella S. Pross H. Friedman 1995 Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydro-cannabinol on murine lymphoid cells Int J Immunopharmacol 17 112 1045 54 8964654 1:CAS:528:DyaK28Xhs12qurw%3D Snella E, Pross S, Friedman H. Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydro-cannabinol on murine lymphoid cells. Int J Immunopharmacol 1995; 17(112): 1045–54
51. 51. Y. Nakano S. Pross H. Friedman 1993 Contrasting effect of delta-9-tetrahydrocannabinol on IL-2 activity in spleen and lymph node cells of mice of different ages Life Sci 52 41 51 8380215 1:CAS:528:DyaK3sXhs1amug%3D%3D Nakano Y, Pross S, Friedman H. Contrasting effect of delta-9-tetrahydrocannabinol on IL-2 activity in spleen and lymph node cells of mice of different ages. Life Sci 1993; 52: 41–51
52. 52. P. Valk S. Verbakel Y. Vankan 1997 Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells Blood 90 1448 57 9269762 1:CAS:528:DyaK2sXltlOktbk%3D Valk P, Verbakel S, Vankan Y, et al. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 1997; 90: 1448–57
53. 53. E.V. Berdyshev E. Boichot N. Germain 1997 Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells Eur J Pharmacol 330 2–3 231 40 9253958 1:CAS:528:DyaK2sXkt1Shtrc%3D Berdyshev EV, Boichot E, Germain N, et al. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur J Pharmacol 1997; 330(2–3): 231–40
54. 54. G.B. Stefano M. Salzet C.M. Rialas 1998 Macrophage behavior associated with acute and chronic exposure to HIV GP 120, morphine and anandamide: endothelial implications Int J Cardiol 64 Suppl.1 S3 13 9687087 Stefano GB, Salzet M, Rialas CM. Macrophage behavior associated with acute and chronic exposure to HIV GP 120, morphine and anandamide: endothelial implications. Int J Cardiol 1998; 64Suppl. 1: S3–13
55. 55. S.C. Shivers C. Newton H. Friedman 1994 Delta 9-tetrahydro-cannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines Life Sci 54 17 1281 9 8164509 1:CAS:528:DyaK2cXis1Whsrk%3D Shivers SC, Newton C, Friedman H, et al. Delta 9-tetrahydro-cannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. Life Sci 1994; 54(17): 1281–9
56. 56. M. Bouaboula C. Poinot-Chazel B. Bourrie 1995 Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 637 41 8526880 1:CAS:528:DyaK2MXpvVentr8%3D Bouaboula M, Poinot-Chazel C, Bourrie B, et al. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 1995; 312 (Pt 2): 637–41
57. 57. K. Trisler S. Specter 1994 Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes Int J Immunopharmacol 16 7 593 603 7523319 1:CAS:528:DyaK2cXksleksb0%3D Trisler K, Specter S. Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes. Int J Immunopharmacol 1994; 16(7): 593–603
58. 58. D.I. Kusher L.O. Dawson A.C. Taylor 1994 Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocan-nabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes Cell Immunol 154 1 99 108 8118892 1:CAS:528:DyaK2cXitlGqtrw%3D Kusher DI, Dawson LO, Taylor AC, et al. Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocan-nabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell Immunol 1994; 154(1): 99–108
59. 59. Y. Daaka W. Zhu H. Friedman 1997 Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor DNA Cell Biol 16 3 301 9 9115639 1:CAS:528:DyaK2sXitlWktLk%3D Daaka Y, Zhu W, Friedman H, et al. Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor. DNA Cell Biol 1997; 16(3): 301–9
60. 60. M.D. Srivastava B.I. Srivastava B. Brouhard 1998 Delta9 tetrahydro-cannabinol and cannabidiol alter cytokine production by human immune cells Immunopharmacology 40 3 179 85 9858061 1:CAS:528:DyaK1cXntVyhu78%3D Srivastava MD, Srivastava BI, Brouhard B. Delta9 tetrahydro-cannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 1998; 40(3): 179–85
61. 61. M. Bouaboula C. Poinot-Chazel J. Marchand 1996 Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression Eur J Biochem 237 704 11 8647116 1:CAS:528:DyaK28XivV2js7w%3D Bouaboula M, Poinot-Chazel C, Marchand J, et al. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 1996; 237: 704–11
62. 62. M. Wartmann D. Campbell A. Subramanian 1995 The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide FEBS Lett 359 133 6 7867785 1:CAS:528:DyaK2MXjvVemsrg%3D Wartmann M, Campbell D, Subramanian A, et al. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 1995; 359: 133–6
63. 63. B. Watzl P. Scuderi R.R. Watson 1991 Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro Int J Immunopharmacol 13 8 1091 7 1667651 1:CAS:528:DyaK38XjsVWntg%3D%3D Watzl B, Scuderi P, Watson RR. Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro. Int J Immunopharmacol 1991; 13(8): 1091–7
64. 64. T. Bisogno S. Maurellis D. Melck 1997 Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes J Biol Chem 272 3315 23 9013571 1:CAS:528:DyaK2sXhtFemu7k%3D Bisogno T, Maurellis S, Melck D, et al. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 1997; 272: 3315–23
65. 65. J.M. Derocq M. Segui J. Marchand 1995 Cannabinoids enhance human B-cell growth at low nanomolar concentrations FEBS Lett 369 177 82 7544292 1:CAS:528:DyaK2MXnslyhsr8%3D Derocq JM, Segui M, Marchand J, et al. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 1995; 369: 177–82
66. 66. K. Fischer-Stenger A.W. Updegrove G.A. Cabrai 1992 Delta 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells Proc Soc Exp Biol Med 200 422 30 1319584 1:CAS:528:DyaK38XltVCjt70%3D Fischer-Stenger K, Updegrove AW, Cabrai GA. Delta 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells. Proc Soc Exp Biol Med 1992; 200: 422–30
67. 67. K. Fischer-Stenger P. D. Dove 1993 Delta 9-tetrahydro-cannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events J Pharmacol Exp Ther 267 3 1558 65 8263818 1:CAS:528:DyaK2cXmvFGjsw%3D%3D Fischer-Stenger K, Dove Pettit DA, et al. Delta 9-tetrahydro-cannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events. J Pharmacol Exp Ther 1993; 267(3): 1558–65
68. 68. M. Bouaboula M. Rinaldi P. Carayon 1993 Cannabinoid-receptor expression in human leukocytes Eur J Biochem 214 1 173 80 8508790 1:CAS:528:DyaK3sXks1aru74%3D Bouaboula M, Rinaldi M, Carayon P, et al. Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 1993; 214(1): 173–80
69. 69. P.J. Valk R. Delwel 1998 The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis Leuk Lymphoma 32 1–2 29 43 10036999 1:CAS:528:DC%2BD3cXlsFSltLs%3D Valk PJ, Delwel R. The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis. Leuk Lymphoma 1998; 32(1–2): 29–43
70. 70. C.C. Felder M. Glass 1998 Cannabinoid receptors and their endogenous agonists Annu Rev Pharmacol Toxicol 38 179 200 9597153 1:CAS:528:DyaK1cXivF2itLw%3D Felder CC, Glass M. Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 1998; 38: 179–200
71. 71. G.A. Gonzalez M.R. Montminy 1989 Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 Cell 59 675 80 2573431 1:CAS:528:DyaK3cXkvFOkuw%3D%3D Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989; 59: 675–80
72. 72. J.M. Derocq M. Bouaboula J. Marchand 1998 The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines FEBS Lett 425 419 25 9563506 1:CAS:528:DyaK1cXitVKhsr8%3D Derocq JM, Bouaboula M, Marchand J, et al. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett 1998; 425: 419–25
73. 73. M. Rinaldi-Carmona F. Barth J. Millan 1998 SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J Pharmacol Exp Ther 284 644 50 9454810 1:CAS:528:DyaK1cXhtFWkt78%3D Rinaldi-Carmona M, Barth F, Millan J, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 1998; 284: 644–50
74. 74. D.J. Stuehr C.F. Nathan 1989 Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells J Exp Med 169 1543 55 2497225 1:CAS:528:DyaL1MXktVGksL8%3D Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543–55
75. 75. L. Feng W. Sun Y. Xia 1993 Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression Arch Biochem Biophys 307 2 361 8 8274023 1:CAS:528:DyaK2cXhtVSns70%3D Feng L, Sun W, Xia Y, et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 1993; 307(2): 361–8
76. 76. M. Yu D. Ives C.S. Ramesha 1997 Synthesis of prostaglandin E 2 ethanolamide from anandamide by cyclooxygenase-2 J Biol Chem 272 21181 6 9261124 1:CAS:528:DyaK2sXls1Ojt7g%3D Yu M, Ives D, Ramesha CS. Synthesis of prostaglandin E 2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 1997; 272: 21181–6
77. 77. M. Shen S.A. Thayer 1998 Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity Mol Pharmacol 54 3 459 62 9730904 1:CAS:528:DyaK1cXmtlGisL0%3D Shen M, Thayer SA. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 1998; 54(3): 459–62
78. 78. T. Nagayama A.D. Sinor R.P. Simon 1999 Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J Neurosci 19 8 2987 95 10191316 1:CAS:528:DyaK1MXitlGnur0%3D Nagayama T, Sinor AD, Simon RP, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 1999; 19(8): 2987–95
79. 79. C. Blazquez C. Sanchez A. Daza 1999 The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme J Neurochem 72 4 1759 68 10098887 1:CAS:528:DyaK1MXitFCkt7o%3D Blazquez C, Sanchez C, Daza A, et al. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. J Neurochem 1999; 72(4): 1759–68
80. 80. C. Sanchez I. Galve-Roperh D. Rueda 1998 Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the delta-9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes Mol Pharmacol 54 5 834 43 9804618 1:CAS:528:DyaK1cXntlOntLY%3D Sanchez C, Galve-Roperh I, Rueda D, et al. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the delta-9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol 1998; 54(5): 834–43
81. 81. F. Molina-Holgado R. Grencis N.J. Rothwell 1999 Interactions of cannabinoids and anti-inflammatory cytokines in astrocyte mice cultures Soc Neurosci Abstr 25 1 1180 Molina-Holgado F, Grencis R, Rothwell NJ. Interactions of cannabinoids and anti-inflammatory cytokines in astrocyte mice cultures. Soc Neurosci Abstr 1999; 25(1): 1180
82. 82. C. Sanchez I. Galve-Roperh C. Canova 1998 Delta-9-tetrahy-drocannabinol induces apoptosis in C6 glioma cells FEBS Lett 436 1 6 10 9771884 1:CAS:528:DyaK1cXmt1emuro%3D Sanchez C, Galve-Roperh I, Canova C, et al. Delta-9-tetrahy-drocannabinol induces apoptosis in C6 glioma cells. FEBS Lett 1998; 436(1): 6–10
83. 83. Y. Waksman J.M. Olson S.J. Carlisle 1999 The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells J Pharmacol Exp Ther 288 3 1357 66 10027878 1:CAS:528:DyaK1MXhs1KisLg%3D Waksman Y, Olson JM, Carlisle SJ, et al. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 1999; 288(3): 1357–66
84. 84. E. Shohami R. Gallily R. Mechoulam 1997 Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant J Neuroimmunol 72 2 169 77 9042110 1:CAS:528:DyaK2sXhslansA%3D%3D Shohami E, Gallily R, Mechoulam R, et al. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J Neuroimmunol 1997; 72(2): 169–77
85. 85. S.A. Hunter C.A. Audette S. Burstein 1991 Elevation of brain prostaglandin E2 levels in rodents by delta 1-tetrahydrocannabinol Prostaglandins Leukot Essent Fatty Acids 43 3 185 90 1651514 1:CAS:528:DyaK3MXltVGqtr4%3D Hunter SA, Audette CA, Burstein S. Elevation of brain prostaglandin E2 levels in rodents by delta 1-tetrahydrocannabinol. Prostaglandins Leukot Essent Fatty Acids 1991; 43(3): 185–90
86. 86. V. Marzo Di A. Fontana H. Cadas 1994 Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 6507 686 91 7990962 Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994; 372(6507): 686–91
87. 87. D.G. Deutsch S.A. Chin 1993 Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist Biochem Pharmacol 46 5 791 6 8373432 1:CAS:528:DyaK2cXhsF2murk%3D Deutsch DG, Chin SA. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 1993; 46(5): 791–6
88. 88. L. Petrocelli De D. Melck N. Ueda 1997 Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase Biochem Biophys Res Commun 231 82 88 De Petrocelli L, Melck D, Ueda N, et al. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem Biophys Res Commun 1997; 231: 82–88
89. 89. T. Bisogno F. Berrendero G. Ambrosino 1999 Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function Biochem Biophys Res Commun 256 377 80 10079192 1:CAS:528:DyaK1MXhvVaiur4%3D Bisogno T, Berrendero F, Ambrosino G, et al. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun 1999; 256: 377–80
90. 90. J.E. Merrill I.S. Chen 1991 HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease FASEB J 5 10 2391 7 2065887 1:STN:280:DyaK3M3ptlCltA%3D%3D Merrill JE, Chen IS. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991; 5(10): 2391–7
91. 91. P.H. Patterson 1995 Cytokines in Alzheimer’s disease and multiple sclerosis Curr Opin Neurobiol 5 5 642 6 8580716 1:CAS:528:DyaK2MXps1yntLs%3D Patterson PH. Cytokines in Alzheimer’s disease and multiple sclerosis. Curr Opin Neurobiol 1995; 5(5): 642–6
92. 92. Y. Hayashi M. Nomura S. Yamagishi 1997 Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes Glia 19 1 13 26 8989564 1:STN:280:DyaK2s7ktlGmsQ%3D%3D Hayashi Y, Nomura M, Yamagishi S, et al. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 1997; 19(1): 13–26
93. 93. Z. Fabry C.S. Raine M.N. Hart 1994 Nervous tissue as an immune compartment: the dialect of the immune response in the CNS Immunol Today 15 5 218 24 8024682 1:CAS:528:DyaK2cXktlamu7k%3D Fabry Z, Raine CS, Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994; 15(5): 218–24
94. 94. J.E. Merrill E.N. Benveniste 1996 Cytokines in inflammatory brain lesions: helpful and harmful Trends Neurosci 19 8 331 8 8843602 1:CAS:528:DyaK28XkvFWitrg%3D Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996; 19(8): 331–8
95. 95. M. Bouaboula B. Bourrie M. Rinaldi-Carmona 1995 Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells J Biol Chem 270 23 13973 80 7775459 1:CAS:528:DyaK2MXmt1yqtr0%3D Bouaboula M, Bourrie B, Rinaldi-Carmona M, et al. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 1995; 270(23): 13973–80
96. 96. M. Rinaldi-Carmona F. Barth M. Heaulme 1994 SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 2–3 240 4 8070571 1:CAS:528:DyaK2cXmsVKjsrw%3D Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994; 350(2–3): 240–4
97. 97. N.J. Rothwell S.J. Hopkins 1995 Cytokines and the nervous system II: actions and mechanisms of action Trends Neurosci 18 3 130 6 7754524 1:CAS:528:DyaK2MXktV2rtbg%3D Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995; 18(3): 130–6
98. 98. N. Rothwell S. Allan S. Toulmond 1997 The role of interleukin-1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications J Clin Invest 100 11 2648 52 9389726 1:CAS:528:DyaK2sXotValur8%3D Rothwell N, Allan S, Toulmond S. The role of interleukin-1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 1997; 100(11): 2648–52
99. 99. M. Aschner 1998 Immune and inflammatory responses in the CNS: modulation by astrocytes Toxicol Lett 102–103 283 7 10022267 Aschner M. Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol Lett 1998; 102–103: 283–7
100. 100. C.S. Raine B. Bonetti B. Cannella 1998 Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque Rev Neurol (Paris) 154 8–9 577 85 1:STN:280:DyaK1M%2Fis12jsg%3D%3D Raine CS, Bonetti B, Cannella B. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Neurol (Paris) 1998; 154(8–9): 577–85
101. 101. K. Selmaj A. Walczak M. Mycko 1998 Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with downregulation of VCAM-1/VLA-4 Eur J Immunol 28 6 2035 44 9645385 1:CAS:528:DyaK1cXjsleit7o%3D Selmaj K, Walczak A, Mycko M, et al. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with downregulation of VCAM-1/VLA-4. Eur J Immunol 1998; 28(6): 2035–44
102. 102. F.M. Hofman D.R. Hinton K. Johnson 1989 Tumor necrosis factor identified in multiple sclerosis brain J Exp Med 170 2 607 12 2754393 1:CAS:528:DyaL1MXltlahsLY%3D Hofman FM, Hinton DR, Johnson K, et al. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170(2): 607–12
103. 103. V. Navikas D. Matusevicius M. Soderstrom 1996 Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis J Neuroimmunol 64 1 63 9 8598391 1:CAS:528:DyaK28XptVSntA%3D%3D Navikas V, Matusevicius D, Soderstrom M. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996; 64(1): 63–9
104. 104. H. Tilg C.A. Dinarello J.W. Mier 1997 IL-6 and APPs: anti-inflammatory and immunosuppressive mediators Immunol Today 18 9 428 32 9293158 1:CAS:528:DyaK2sXlvVGgsLk%3D Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18(9): 428–32
105. 105. E.N. Benveniste L.P. Tang R.M. Law 1995 Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10 Int JDev Neurosci 13 3–4 341 9 1:CAS:528:DyaK2MXnt1eqtbk%3D Benveniste EN, Tang LP, Law RM, et al. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int JDev Neurosci 1995; 13(3–4): 341–9
106. 106. P. Consroe R. Musty J. Rein 1997 The perceived effects of smoked cannabis on patients with multiple sclerosis Eur Neurol 38 1 44 8 9252798 1:STN:280:DyaK2szps1Khtw%3D%3D Consroe P, Musty R, Rein J, et al. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38(1): 44–8
107. 107. R.R. Leker E. Shohami O. Abramsky 1999 Dexanabinol: a novel neuroprotective drug in experimental focal cerebral ischemia J Neurol Sci 162 2 114 9 10202976 1:CAS:528:DyaK1MXpslWnsA%3D%3D Leker RR, Shohami E, Abramsky O, et al. Dexanabinol: a novel neuroprotective drug in experimental focal cerebral ischemia. J Neurol Sci 1999; 162(2): 114–9
108. 108. A. Biegon 1995 Neuroprotective activity of HU-211, a novel non-psychotropic synthetic cannabinoid Ann NY Acad Sci 765 314 7486626 1:STN:280:DyaK28%2FkvFKjtA%3D%3D Biegon A. Neuroprotective activity of HU-211, a novel non-psychotropic synthetic cannabinoid. Ann NY Acad Sci 1995; 765: 314
109. 109. T.M. Westlake A.C. Howlett T.I. Bonner 1994 Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer’s brains Neuroscience 63 637 52 7898667 1:CAS:528:DyaK2MXisFeqtbk%3D Westlake TM, Howlett AC, Bonner TI, et al. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer’s brains. Neuroscience 1994; 63: 637–52
110. 110. L. Volicer M. Stelly J. Morris 1997 Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease Int J Geriatr Psychiatry 12 913 9 9309469 1:STN:280:DyaK2svlsFSrtA%3D%3D Volicer L, Stelly M, Morris J, et al. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 1997; 12: 913–9
111. 111. B.A. Berglund D.L. Boring G.H. Wilken 1998 Structural requirements for arachidonylethanolamide interaction with CB 1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups Prostaglandins Leukot Essent Fatty Acids 59 111 8 9774174 1:CAS:528:DyaK1cXmtlGiuro%3D Berglund BA, Boring DL, Wilken GH, et al. Structural requirements for arachidonylethanolamide interaction with CB 1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups. Prostaglandins Leukot Essent Fatty Acids 1998; 59: 111–8